🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

254 results for “Fen” Clear

  1. Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

    Pfizer Australia Pty Ltd

    Solid tumors

    approved small molecule active

    1 trial

  2. Cufence 200 mg hard capsules

    Univar Solutions BV

    Wilson’s Disease

    approved small molecule active

    1 trial

  3. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  4. Fenfluramine

    United Therapeutics Europe Ltd

    Cognitive Function

    approved small molecule completed

    1 trial

  5. Fenofibrate 145 mg

    United Therapeutics Europe Ltd

    Diabetic Retinopathy

    approved small molecule completed

    1 trial

  6. Fentanyl Buccal Tablet (FBT)

    Teva Pharma GmbH

    Cancer Pain

    approved small molecule terminated

    1 trial

  7. Fentanyl Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Function Loss

    approved small molecule active

    1 trial

  8. Fentanyl hameln 50 microgram/ml, oplossing voor injectie, Narcan Nasal Spray, Sufentanil Eurocept 5 microgram/ml, oplossing voor injectie, Zofran 4 Injectie, Naloxon HCl-hameln 0,4 mg/ml, oplossing voor injectie/infusie

    Disc Medicine

    healthy volunteers, opioid use disorder

    approved small molecule active

    1 trial

  9. Fexofenadine

    Sanofi Pasteur

    Rhinitis, Allergic, Perennial

    approved small molecule completed

    1 trial

  10. Fexofenadine HCL and pseudoephedrine HCL

    Sanofi Pasteur

    Rhinitis Allergic

    approved small molecule completed

    1 trial

  11. Hyperbaric bupivacaine+Sufentanil

    Lxo Ireland Designated Activity Company

    Anesthesia; Functional

    approved small molecule completed

    1 trial

  12. IV Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Pelvic Pain

    approved small molecule active

    1 trial

  13. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Arthroscopic Knee Surgery

    approved small molecule completed

    1 trial

  14. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  15. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  16. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Ductus Arteriosus, Patent

    approved small molecule terminated

    1 trial

  17. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Obesity

    approved small molecule completed

    1 trial

  18. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    approved small molecule terminated

    1 trial

  19. Intravenous fentanyl citrate

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  20. Intravenous ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    3 trials

  21. LETROZOLE, RIBOCICLIB, GOSERELIN ACETATE, LEE011, TAMOXIFEN

    Novartis Pharmaceuticals

    HR+, HER2- advanced or metastatic breast cancer

    approved small molecule active

    1 trial

  22. Placebo suspension is identical to Symbioflor®2 liquid formulation in appearance, weight and composition, with the exception that the active ingredient will be omitted. Placebo constitutes are sodium chloride, magnesium sulphate 7H2O, potassium chloride, calcium chloride 2H2O, magnesium chloride 6H2O, and purified water, Symbioflor 2 Tropfen zum Einnehmen, Suspension

    Alphapharm Pty Ltd

    Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  23. Prednisolone 5mg Soluble Tablets, Certican 0,75 mg tablety, Mycofenolaat mofetil Sandoz 250 mg, capsules, hard, Envarsus 0.75 mg prolonged-release tablets, Simulect 20 mg powder and solvent for solution for injection or infusion, Ciclosporine Teva 25 mg, zachte capsules

    Disc Medicine

    kidney transplant

    approved small molecule active

    1 trial

  24. Prednisona Pensa 5 mg comprimidos EFG, Simulect 20 mg powder for solution for injection or infusion, tacrolimus cinfa 1 mg cápsulas duras EFG, Micofenolato Mofetile Accord 250 mg capsule rigide, Metilprednisolona NORMON 40 mg polvo y disolvente para solución inyectable EFG, TIMOGLOBULINA 5 mg/ml, polvo para solución para perfusión

    The George Institute

    Kidney Transplant

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources